The molecular chaperone GRP78/BiP in the development of chemoresistance: mechanism and possible treatment
Treatment of several types of cancer such as lung, breast, prostate and pancreas has shown notable progresses in the past decades. However, after an initial response, tumors eventually became resistant to chemotherapy. This phenomenon, known as chemoresistance, accounts for the death of most cancer...
Saved in:
Main Authors: | Corinna eRoller (Author), Danilo eMaddalo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2013-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endoplasmic Reticulum Stress-Associated Chaperones, Bip/GRP78 and Calnexin are Overexpressed in Keratocystic Odontogenic Tumours
by: Maria Pavli, et al.
Published: (2014) -
GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson's Disease: A Mini Review
by: Adaze Bijou Enogieru, et al.
Published: (2019) -
COVID19 associated mucormycosis: Is GRP78 a possible link?
by: Jyotsna Gumashta, et al.
Published: (2021) -
SIL1, the endoplasmic-reticulum-localized BiP co-chaperone, plays a crucial role in maintaining skeletal muscle proteostasis and physiology
by: Viraj P. Ichhaporia, et al.
Published: (2018) -
BIK and GRP78 protein expression as possible markers of response to preoperative chemotherapy and survival in breast cancer
by: Cervantes-Díaz María Teresa de Jesús, et al.
Published: (2021)